Fox Business

FDA delays Moderna for adolescents to review rare side effect

The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -1.69% COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of a rare ...
9NEWS

Moderna's COVID-19 vaccine safe for children 6 and older, FDA expert panel says

NEW YORK — A government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens. The Food and Drug Administration's outside experts voted unanimously that ...
AZ Central

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

“The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,” said Stéphane Bancel, Chief Executive Officer of ...
Tennessean

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...
WTVD

Moderna COVID vaccine performs as well in children as it does in adults, company says

CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...